It is not for the faint of heart to invest in startups. Money from founders, friends, and family (FF&F) can easily be lost with little to show for it. Investing in venture capital funds diversifies some risks, but it also forces investors to face the harsh reality that 90% of companies funded will not make it to their initial public offering (IPO).
The CEO of INNEXO; a big name in the biotechnology industry, David Jonathan Benouaich gives a statement in which he expresses that he is planning to create a wide range of his company in the upcoming year 2022. In his recent interview, he elaborated his idea of investing in startups by saying,” In this world, people are always looking for an avenue to grow and make money so investing in companies is very appealing. I’m deeply excited about the ongoing trend of emerging startups in the biotech industry. There is great scope in this field. This exciting process diverts funds from the high-tech industry to biotech, therefore, positioning it as a major field in the business. I think COVID-19 helped a lot in positioning the biotech industry in such a prioritized position.”
Financial Backbone
INNEXO is working as a financial backbone for about thousands of startup companies and industries. Companies and research centres having a strong aim to contribute in the scientific approach are the most deserving candidates on the INNEXO investment list. Research and medical centres, which provide the drug treatments and other cell therapies to cure different health related problems.
David Jonathan Benouaich completes his masters degree in finance. Later on, he pursued his career as a market analyst. His aim was to gather technologists from all over the world for the betterment of the industrial world. He achieved his goal in a very short period by convincing the Agro-Tech and Infra-Tech companies to get access to the non-developing countries.
He further talked about the basic and main idea behind the creation of INNEXO. This idea came from observing the functions of stem cells and their impact on regeneration cells inside the tissue. This gave him the complete modern vision of the biotechnological industry. His aim before establishing this finance and biotechnological company was to provide a helping hand to all the hardworking startups by providing them with enough financial support. He was also pretty sure and ambitious regarding the bright future of INNEXO.
He also gives his opinion about the upcoming startup companies with bigger aims. “I’m a great fan of the lean startup approach. The minimal question underlying every business assumption I have in mind. Once I ask the basic question, I think of what is needed in order to answer it: money-wise, timewise, HR-wise. Then I make a plan, and I try to have the same team of entrepreneurs working with me on every new company.”
Young Entrepreneurs
His expectations towards the new generation of entrepreneurs are very high. He believes in the time supremacy, and he also advised the growing entrepreneurs in his interview by saying, “Ask yourself 5 times “why”. Every fundamental or emotional decision can generate brilliant inputs when you ask 5 times why. It gets you to the core of your desires and needs in life. It provides an extra angel to your daily decisions.”
He further said that he is very conscious about including the companies in his investment portfolio. In 2022, we will get to know about those lucky startups and other companies which made it successfully to his investment portfolio.
